eRNAs and Superenhancer lncRNAs Are Functional in Human Prostate Cancer

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left"></td><td class="align_center">Total</td><td class="align_center">DEN database</td><td class="align_center">ENCODE</td><td class="align_center">GSE82204</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">All eRNA sources</td><td class="align_center">43680</td><td class="align_center">40462</td><td class="align_center">484</td><td class="align_center">2734</td></tr><tr><td class="align_left">Differentially expressed eRNA sources</td><td class="align_center">681</td><td class="align_center">658</td><td class="align_center">3</td><td class="align_center">20</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>The sources of eRNAs and differentially expressed eRNAs in a microarray.</div>

Disease Markers

tab1

Table 1

Table 1: eRNAs and Superenhancer lncRNAs Are Functional in Human Prostate Cancer 